Alberta Investment Management Corp Sarepta Therapeutics, Inc. Transaction History

Alberta Investment Management Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$113.33 - $163.85 $1.76 Million - $2.54 Million	15,500 New	15,500 $2.45 Million
Q3 2020 Oct 26, 2020	SELL	$127.12 - $172.34 $10.2 Million - $13.8 Million	-80,272 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$93.0 - $171.7 $1.21 Million - $2.23 Million	12,963 Added 19.26%	80,272 $12.9 Million
Q1 2020 May 08, 2020	BUY	$82.38 - $131.64 $1.01 Million - $1.61 Million	12,235 Added 22.22%	67,309 $6.58 Million
Q3 2019 Oct 23, 2019	BUY	$72.81 - $156.91 $1.35 Million - $2.91 Million	18,557 Added 50.82%	55,074 $4.15 Million
Q1 2019 May 15, 2019	BUY	$106.67 - $151.68 $657,087 - $934,348	6,160 Added 20.29%	36,517 $4.35 Million
Q4 2018 Feb 14, 2019	BUY	$97.32 - $148.76 $715,983 - $1.09 Million	7,357 Added 31.99%	30,357 $3.31 Million
Q3 2018 Nov 16, 2018	BUY	$115.31 - $161.51 $2.65 Million - $3.71 Million	23,000 New	23,000 $3.72 Million

528

85M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.79B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

Stay updated on Alberta Investment Management Corp with notifications on news.